PMID- 28659882 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230804 IS - 1664-302X (Print) IS - 1664-302X (Electronic) IS - 1664-302X (Linking) VI - 8 DP - 2017 TI - Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis. PG - 1057 LID - 10.3389/fmicb.2017.01057 [doi] LID - 1057 AB - Paracoccidioidomycosis (PCM) is an endemic systemic mycosis in Latin America, with the highest prevalence in Brazil, Colombia, and Venezuela. Fungi of the Paracoccidioides genus are etiologic agents of the disease. The 15 amino acid peptide P10 is derived from gp43, the main diagnostic antigen of Paracoccidioides brasiliensis. We previously reported that P10-pulsed dendritic cells (DCs) induce a protective response against P. brasiliensis. Presently, dexamethasone-treated BALB/c mice were intratracheally infected with P. brasiliensis Pb18 to establish the therapeutic efficacy of P10-pulsed DCs. Immunosuppressed and infected animals that received DCs had a reduction in their fungal burden, and this result was most pronounced in mice receiving DCs primed with P10. The efficacy of therapeutic DCs was significantly augmented by concomitant treatment with trimethoprim-sulfamethoxazole. Additionally, primed-DCs with or without the antifungal drug induced a beneficial Th(1)-biased immune response and significantly reduced tissue damage. In conclusion, these studies with immunocompromised mice demonstrate that P10-pulsed DCs with or without concomitant antifungal drugs are potently effective in combating invasive PCM. These findings support further translational studies to validate the use of P10-primed DCs for PCM in immunocompetent and immunosuppressed hosts. FAU - Silva, Leandro B R AU - Silva LBR AD - Laboratory of Medical Mycology, Tropical Medicine Institute USP-LIM53, University of Sao PauloSao Paulo, Brazil. FAU - Dias, Lucas S AU - Dias LS AD - Department of Microbiology, Institute of Biomedical Sciences, University of Sao PauloSao Paulo, Brazil. FAU - Rittner, Glauce M G AU - Rittner GMG AD - Department of Microbiology, Institute of Biomedical Sciences, University of Sao PauloSao Paulo, Brazil. FAU - Munoz, Julian E AU - Munoz JE AD - Department of Microbiology, Institute of Biomedical Sciences, University of Sao PauloSao Paulo, Brazil. FAU - Souza, Ana C O AU - Souza ACO AD - Department of Microbiology, Institute of Biomedical Sciences, University of Sao PauloSao Paulo, Brazil. FAU - Nosanchuk, Joshua D AU - Nosanchuk JD AD - Department of Medicine, Albert Einstein College of Medicine, BronxNY, United States. AD - Department of Microbiology and Immunology, Albert Einstein College of Medicine, BronxNY, United States. FAU - Travassos, Luiz R AU - Travassos LR AD - Department of Microbiology, Immunology and Parasitology, Federal University of Sao PauloSao Paulo, Brazil. FAU - Taborda, Carlos P AU - Taborda CP AD - Laboratory of Medical Mycology, Tropical Medicine Institute USP-LIM53, University of Sao PauloSao Paulo, Brazil. AD - Department of Microbiology, Institute of Biomedical Sciences, University of Sao PauloSao Paulo, Brazil. LA - eng GR - R01 AI052733/AI/NIAID NIH HHS/United States GR - R21 AI124797/AI/NIAID NIH HHS/United States PT - Journal Article DEP - 20170614 PL - Switzerland TA - Front Microbiol JT - Frontiers in microbiology JID - 101548977 PMC - PMC5469887 OTO - NOTNLM OT - P10 OT - Paracoccidioides brasiliensis OT - adjuvants OT - dendritic cells OT - paracoccidioidomycosis OT - vaccine EDAT- 2017/07/01 06:00 MHDA- 2017/07/01 06:01 PMCR- 2017/06/14 CRDT- 2017/06/30 06:00 PHST- 2016/10/10 00:00 [received] PHST- 2017/05/26 00:00 [accepted] PHST- 2017/06/30 06:00 [entrez] PHST- 2017/07/01 06:00 [pubmed] PHST- 2017/07/01 06:01 [medline] PHST- 2017/06/14 00:00 [pmc-release] AID - 10.3389/fmicb.2017.01057 [doi] PST - epublish SO - Front Microbiol. 2017 Jun 14;8:1057. doi: 10.3389/fmicb.2017.01057. eCollection 2017.